Suppr超能文献

比较多种简化的多参数 MRI 衍生方案在检测临床显著前列腺癌中的应用。

Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer.

机构信息

Institute of Radiology, Santa Maria della Misericordia Academic Medical Center, Udine, Italy.

Unit of Urology, Santa Maria della Misericordia Academic Medical Center, Udine, Italy -

出版信息

Minerva Urol Nephrol. 2022 Feb;74(1):29-37. doi: 10.23736/S2724-6051.20.03952-1. Epub 2020 Oct 5.

Abstract

BACKGROUND

The aim of this paper was to compare the accuracy of multiple abbreviated multiparametric magnetic resonance imaging (mpMRI)-derived protocols in detecting clinically significant prostate cancer (csPCa).

METHODS

One hundred and eight men undergoing staging 3.0T mpMRI with a Prostate Imaging - Reporting and Data System version 2 (PI-RADSv2)-compliant protocol before radical prostatectomy (RP) were retrospectively evaluated. Two readers (R1, R2) independently analyzed mpMRI, assigning a PI-RADSv2 category to each observation as appearing on each examination sequence. A study coordinator assessed final PI-RADSv2 category by combining readers' assignments according to four protocols: short MRI (sMRI) (diffusion-weighted imaging + axial T2-weighted imaging), contrast-enhanced short MRI (cesMRI) (sMRI + dynamic contrast-enhanced [DCE] imaging), biparametric MRI (diffusion-weighted imaging + multiplanar T2-weigthed imaging), and mpMRI. Using RP pathology as the reference standard for csPCa, we calculated the per-lesion cancer detection rate (CDR) and false discovery rate (FDR) for each MRI protocol (cut-off PI-RADSv2 category ≥3), and the per-PI-RADSv2 category prevalence of csPCa and false positives.

RESULTS

Pathology after RP found 142 csPCas with median International Society of Urogenital Pathology grade group 2, and stage ≤pT2c in 68.6% of cases. CDR was comparable across the four MRI protocols (74.6% to 75.3% for R1, and 68.3% for R2). FDR was comparable as well (14.4%-14.5% for R1 and 11.1% for R2). sMRI was the minimum protocol equaling mpMRI in terms of CDR, although cesMRI, similarly to mpMRI, was associated with fewer PI-RADSv2 category 3 assignments and higher prevalence of csPCa within PI-RADSv2 category 3 observations (66.7% versus 76.9% for R1, and 100% versus 91.7% for R2, respectively).

CONCLUSIONS

Among multiple abbreviated mpMRI-derived protocols, cesMRI was the one equaling mpMRI in terms of csPCa detection and minimizing PI-RADSv2 category 3 assignments.

摘要

背景

本文旨在比较多种简化的多参数磁共振成像(mpMRI)衍生方案在检测临床显著前列腺癌(csPCa)方面的准确性。

方法

回顾性分析 108 例在根治性前列腺切除术(RP)前接受 3.0T 分期 mpMRI 检查的患者,这些患者均符合前列腺成像报告和数据系统第 2 版(PI-RADSv2)协议。两位读者(R1、R2)独立分析 mpMRI,根据每个检查序列上的表现为每个观察分配 PI-RADSv2 类别。一位研究协调员根据以下四个方案组合读者的分配来评估最终的 PI-RADSv2 类别:简化 MRI(sMRI)(弥散加权成像+轴位 T2 加权成像)、增强简化 MRI(cesMRI)(sMRI+动态对比增强[DCE]成像)、双参数 MRI(弥散加权成像+多平面 T2 加权成像)和 mpMRI。以 RP 病理学为 csPCa 的参考标准,我们计算了每个 MRI 方案(PI-RADSv2 类别≥3)的病变癌检出率(CDR)和假阳性率(FDR),以及每个 PI-RADSv2 类别中 csPCa 和假阳性的发生率。

结果

RP 术后病理发现 142 例 csPCa,中位国际泌尿病理学会(ISUP)分级组 2,68.6%的病例为 pT2c 期。四种 MRI 方案的 CDR 相当(R1 为 74.6%至 75.3%,R2 为 68.3%)。FDR 也相当(R1 为 14.4%-14.5%,R2 为 11.1%)。sMRI 在 CDR 方面与 mpMRI 相当,尽管 cesMRI 与 mpMRI 一样,与更少的 PI-RADSv2 类别 3 分配和更高的 PI-RADSv2 类别 3 观察中 csPCa 的发生率相关(R1 为 66.7%比 76.9%,R2 为 100%比 91.7%)。

结论

在多种简化的 mpMRI 衍生方案中,cesMRI 在 csPCa 检测和最小化 PI-RADSv2 类别 3 分配方面与 mpMRI 相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验